Call to Schedule Free Consultation at Over 80 Centers Worldwide!
Autoimmune
Cardiovascular
Endocrine
Gastrointestinal
Liver
Musculoskeletal
Neurological
Other
Respiratory/Pulmonary
Reproductive
Renal/Kidney
Urologic
Autoimmune
Cardiovascular
Endocrine
Gastrointestinal
Liver
Musculoskeletal
Neurological
Other
Respiratory/Pulmonary
Reproductive
Renal/Kidney
Urologic
R3 Stem Cell provides Murfreesboro and Rutherford County with non-surgical regenerative medicine consultations, including PRP, mesenchymal stem cell therapy, and exosome treatments, without requiring travel to Nashville. Some treatments remain investigational under FDA guidelines, and the clinic states this disclosure before consultation.
Murfreesboro’s population approaches 170,000 with a median age of 31. The Greenway System covers 17 miles of trails along the Stones River and Lytle Creek; Barfield Crescent Park adds 7 miles of hiking and athletic fields. That daily activity accumulates.
Greenway runners, MTSU student-athletes, and Rutherford County workers in manufacturing and logistics regularly manage persistent joint pain, partial ligament injuries, and early degenerative changes — conditions not yet at surgical candidacy but unresolved by rest or physical therapy alone. Regenerative medicine is one option when those approaches leave a gap.
Request Your Free Stem Cell Evaluation
Platelet-Rich Plasma (PRP): PRP concentrates growth factors from your own blood to support tissue healing and reduce inflammation — one of the most clinically studied biologic interventions in musculoskeletal care.
Mesenchymal Stem Cells (MSCs): MSC-based treatments modulate inflammation and signal tissue repair. Sources include bone marrow or donor Wharton’s jelly from umbilical cord tissue.
Exosome Therapy: Exosomes are cell-signaling particles under active investigation; orthopedic use is currently investigational.
PRP and stem cell therapy differ in mechanism, sourcing, and clinical application. Not every patient qualifies — physical therapy, medication management, or surgical referral is recommended when those paths are more appropriate.
Knee pain and osteoarthritis
Stem Cell Therapy for Knee Arthritis is among the most researched orthopedic regenerative applications, particularly for Greenway runners and adults with early degenerative joint changes.
Lower back and disc pain
Murfreesboro's manufacturing and commuter workforce frequently explores Stem Cell Therapy for Degenerative Disc Disease before pursuing invasive options.
Hip arthritis
Hip Arthritis response varies by severity and joint space; evaluation determines candidacy.
Rotator cuff and shoulder injuries
Partial tears and chronic tendinopathy are where Stem Cell Therapy for Rotator Cuff Injury has the strongest evidence.
Ankle and foot pain
Plantar Fasciitis and Achilles Tendinopathy are the most common tendon referrals from Rutherford County patients.
Elbow, wrist, and hand
Elbow Tendonitis and wrist instability from repetitive strain, common in trades and manufacturing.
Cervical pain
Neck Pain in desk workers and commuters where conservative care has produced incomplete relief.
We review medical history, symptoms, prior treatments, and imaging — MRI, X-ray, or ultrasound. Local imaging centers in Murfreesboro and Rutherford County are identified when new scans are needed.
Every option is explained by procedure, biologic source (autologous vs. donor-derived), and FDA 351 or 361 HCT/P classification. Realistic outcome ranges and consequences of non-response are covered before any decision. Full informed consent documentation is provided.
Outpatient; local anesthesia; ultrasound guidance available; typically under two hours. Written aftercare and scheduled follow-up included. Patients can review how stem cell therapy works at a clinical level before their appointment.
Products using minimally manipulated autologous tissue may qualify under FDA 361 HCT/P. Others require 351 biologic approval. Others are investigational. The relationship between stem cells and the FDA is more nuanced than most patients expect — we explain every classification in plain language before treatment.
With patient consent, our clinical providers share findings and treatment notes with primary care physicians, orthopedic specialists, physical therapists, and imaging centers across Rutherford County. Regenerative care complements existing treatment — it does not replace it.
Most regenerative procedures are not covered by Medicare or private insurance. Before scheduling: pricing is provided in writing, stem cell therapy financing options are reviewed, and applicable clinical research opportunities are identified. No hidden costs. No procedure is scheduled before pricing is confirmed.
When a relevant clinical trial exists, we explain eligibility, responsibilities, protocol risks, and how research differs from standard treatment. Participation is voluntary. Stem cell research evolves continuously — clinical protocols are updated accordingly.
Outcomes vary by patient age, health status, condition chronicity, biologic product, and delivery precision. Some patients report improvement within four to six weeks; others take three to six months; some do not respond. We do not guarantee outcomes. Patients can review what to expect from stem cell therapy before their appointment. When surgery is the clearer path, we say so and facilitate the referral.
Directness. Established vs. investigational vs. uncertain — clearly distinguished at every step. Convenience. No Nashville commute. Local imaging coordination included. Coordination. Findings shared with your existing Rutherford County care team. Biologic access. PRP, umbilical cord stem cell therapy, and exosomes — not widely available in standard orthopedic practice. No pressure. Our therapy commitment defines what patients can expect at every stage.
Yes. Patellar tendinopathy, IT band syndrome, and plantar fasciitis are common regenerative referrals. PRP has a growing evidence base for tendon conditions. Candidacy depends on injury type, duration, and severity.
Yes. R3 Stem Cell serves all of Rutherford County. Initial consultations can often be conducted remotely.
Yes. We coordinate with athletic training and sports medicine teams and avoid recommending procedures that conflict with active rehabilitation.
We address the gap between conservative care and surgery — for patients not yet at surgical candidacy but unresolved by conventional treatment. We complement orthopedic care, not replace it.
Most orthopedic regenerative procedures are not FDA approved for specific indications. Some are regulated under HCT/P guidelines; others are investigational. We classify every option we discuss.
Generally no. Self-pay. Pricing confirmed in writing before any commitment. Financing available.
Four to six weeks for some; three to six months for others; no response for some. Full outcome range discussed before proceeding.
Disclaimer: Stem cell therapy is experimental and not FDA-approved. R3 Stem Cell does not offer these treatments as a cure for any condition. No content on this site constitutes medical advice, diagnosis, or treatment — it is for informational purposes only. Always consult a qualified healthcare provider before making medical decisions. Reliance on any information provided by R3 Stem Cell is solely at your own risk. R3 Stem Cell is not responsible for individual treatment outcomes.
Brand Ambassador Gallery
Free Webinar with R3 Stem Cell
All You Need to Know About Stem Cell Therapy Presented by CEO David Greene, MD, PhD, MBA!
Register Now For Free Webinar: Avoid Surgery With Stem Cell Therapy
R3 Stem Cell Master Class
Learn everything you need to know about the ever expanding field of regenerative medicine in this 8 part series that includes over four hours of entertaining content!
R3 Stem Cell International
R3 Stem Cell International includes 80 clinics in 8 countries. These Centers of Excellence treat all types of conditions with safe, effective protocols by expert stem cell physicians.
Free Stem Cell Consultation
R3 Stem Cell offers a no cost consultation to see if you or a loved one is a candidate for regenerative cell therapies including cytokines, growth factors, exosomes, and stem cells.
Provider
Partnership
The R3 Partnership Program offers providers an all-in-one regenerative practice program including marketing, consultations and booked procedures!
Success Stories
*Outcomes will vary between individuals. No claims are being made with regenerative therapies. The FDA considers stem cell therapy experimental. See our THERAPY COMMITMENT HERE.
The USA Stem Cell Leader Offers Procedures In 8 Countries Including
United States
Mexico
Philippines
South Africa
Pakistan
India
Turkey
UAE
Call to schedule your free consultation at over 80 centers world!
About Us
R3 Stem Cell is a global leader in regenerative medicine, offering advanced stem cell and exosome therapies through Centers of Excellence in over 8 locations across 80 countries. Our mission is to provide first-rate, customized… regenerative
Contact Us
Main menu
Subscribe Newsletter
Contact Detail
CALIFORNIA
FLORIDA
GEORGIA
HAWAII
IDAHO
ILLINOIS
INDIANA
IOWA
KANSAS
KENTUCKY
LOUISIANA
MARYLAND
MASSACHUSETTS
MICHIGAN
MINNESOTA
MISSISSIPPI
MISSOURI
NEBRASKA
NEW JERSEY
NEW YORK
NEW MEXICO
NEVADA
NORTH CAROLINA
OHIO
OKLAHOMA
OREGON
PENNSYLVANIA
RHODE ISLAND
SOUTH CAROLINA
SOUTH DAKOTA
TENNESSEE
Disclaimer
Stem cell therapy is considered experimental and is regulated by the U.S. Food and Drug Administration (FDA), but it is not FDA-approved. R3 Stem Cell does not offer stem cell therapy as a cure for any medical condition. No statements made on this site have been evaluated or approved by the FDA. This site does not provide medical advice. All content is for informational purposes only and is not a substitute for professional medical consultation, diagnosis, or treatment. Reliance on any information provided by R3 Stem Cell, its employees, others appearing on this website at the invitation of R3 Stem Cell, or other visitors to the website is solely at your own risk. R3 Stem Cell does not recommend or endorse any specific tests, products, procedures, opinions, or other information that may be mentioned on this website. R3 Stem Cell is not responsible for the outcome of your procedure. The FDA considers stem cell therapy experimental at this point.
Copyright © 2017-2026 R3 Stem Cell. All Rights Reserved.